GlassScriptPhysician profile
Bradley H Bennett
NPI 1609985613
$1,863.50
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $82.45 · 2021: $138 · 2022: $32.51 · 2023: $72.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,404.37 | 2019-2023 | Da Vinci Surgical System |
| Covidien LP | $102.40 | 2019 | |
| Braintree Laboratories, INC. | $99.91 | 2019-2021 | |
| Baudax Bio INC. | $45.77 | 2020-2021 | |
| Innovation Technologies INC | $37.51 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.86 | 2020-2022 | |
| Baxter Healthcare | $33.00 | 2019 | |
| Ethicon US, LLC | $19.81 | 2022 | |
| Merck Sharp & Dohme LLC | $19.57 | 2019 | |
| Trevena, INC. | $16.32 | 2021 | |
| Boston Scientific Corporation | $15.14 | 2020 | |
| Tela Bio, INC. | $13.53 | 2021 | |
| Smith+Nephew, INC. | $11.17 | 2021 | |
| Acell, INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.